Abstract:Sustainable social activity is a major goal in an aging society, although this is limited by loss of athleticism, with osteoporosis-related fractures being the most common cause of long-term behavioral restrictions in older people. Therefore, the development of therapeutics that shorten the duration of fracture therapy is essential to improve the quality of life and social activity of older individuals. In this study, we developed a polyethylene glycol-modified alendronate (PEG-ALN) that can efficiently deliver the active ingredient (ALN) to fracture sites. PEG-ALN released ALN in response to an acidic pH and was systemically administered to mice in a fracture model. PEG-ALN exhibited selective accumulation at the fracture site and significantly accelerated bone healing compared to free ALN. This study highlights the utility of a simple polymer modification of ALN as a systemically injectable medicine for patients with bone fractures. Bone fractures present a significant risk to the health and quality of life of older individuals in aging societies. However, there are limited options for direct pharmacological treatment of fractures. In this study, we optimized a commonly used but therapeutically challenging drug, alendronate (ALN), to target and improve fracture healing. We modified alendronate with high molecular weight polyethylene glycol (PEG) through an acidic-responsive linker (PEG-ALN) and assessed its effect on osteoblasts and osteoclasts, and thereby on bone healing, both in vitro and in vivo. This PEGylation prevented the rapid clearance of ALN in a mouse fracture model and enabled specific accumulation of PEG-ALN at fracture sites. The accumulated PEG-ALN is cleaved by the acidic environment of these osteoclastic regions to release active ALN directly where required. Consequently, the fracture region is converted to an osteoblast-dominated environment with increased recovery of bone fractures. Thus, our study demonstrated that PEG-ALN provides an effective delivery system for ALN to fracture sites, enabling rapid healing without apparent side effects. We believe that the findings of this study are relevant to the scope of your journal as they address the biomedical use of materials that could enhance debilitating conditions that will become more frequent in a rapidly aging population.

Enhancing Alendronate Release from a Novel PLGA/hydroxyapatite Microspheric System for Bone Repairing Applications.

Synthesis, Characterization And Osteoconductivity Properties Of Bone Fillers Based On Alendronate-Loaded Poly(Epsilon-Caprolactone)/Hydroxyapatite Microspheres

Synthesis, characterization and osteoconductivity properties of bone fillers based on alendronate-loaded poly(ε-caprolactone)/hydroxyapatite microspheres

A Novel PHBV/HA Microsphere Releasing System Loaded with Alendronate

A sustained release of alendronate from an injectable tetra-PEG hydrogel for efficient bone repair

Emulsion Cross-Linked Chitosan/nanohydroxyapatite Microspheres for Controlled Release of Alendronate

PLGA-BMP-2 and PLA-17β-Estradiol Microspheres Reinforcing a Composite Hydrogel for Bone Regeneration in Osteoporosis

Reconstruction of Large-scale Defects with a Novel Hybrid Scaffold Made from Poly(L-lactic Acid)/nanohydroxyapatite/alendronate-Loaded Chitosan Microsphere: in Vitro and in Vivo Studies

Biomimetic mineralization of nanocrystalline hydroxyapatites on aminated modified polylactic acid microspheres to develop a novel drug delivery system for alendronate

In vitro/ex vivo evaluation of multifunctional collagen/chitosan/hyaluronic acid hydrogel-based alendronate delivery systems

PLGA porous microspheres enhancing the osteogenesis of MC 3 T 3E 1 cells

In Vivo and in Vitro Osteogenesis of Stem Cells Induced by Controlled Release of Drugs from Microspherical Scaffolds

Study of Injectable Hydrogel Based on ALN/Nha Promoting Osteogenesis And Inhibiting Osteoclasts in Osteoporotic Bone Defects Repair

A Bone Targeting Nanoparticle Loaded Ogp to Restore Bone Homeostasis for Osteoporosis Therapy

Alendronate delivery on amino modified mesoporous bioactive glass scaffolds to enhance bone regeneration in osteoporosis rats

Bioactive apatite incorporated alginate microspheres with sustained drug-delivery for bone regeneration application

Novel Mesoporous Silica-Based Antibiotic Releasing Scaffold for Bone Repair

Alendronate modified mPEG-PLGA nano-micelle drug delivery system loaded with astragaloside has anti-osteoporotic effect in rats

Site-activatable targeting of macromolecular alendronate for accelerated fracture healing

Alendronate-functionalized double network hydrogel scaffolds for effective osteogenesis

A Protein/Antibiotic Releasing Poly(Lactic-Co-Glycolic Acid)/Lecithin Scaffold for Bone Repair Applications